Junior Project Manager – Clinical Development

Job Title:

JUNIOR PROJECT MANAGER – CLINICAL DEVELOPMENT

Department:
Others

Philochem AG is the discovery R&D center of the Philogen Group, a Swiss-Italian biotechnology company developing innovative biopharmaceuticals for cancer and inflammatory diseases. Located near Zurich, Philochem integrates chemistry, biology, cell line development, and mass spectrometry to advance new therapeutic and diagnostic candidates from discovery toward clinical development.

Philochem AG, part of the Philogen Group, is seeking a highly motivated Junior Project Manager with a strong scientific background to join its Clinical Development and Project Management team. The successful candidate will contribute to the scientific and operational management of clinical development programs, with a particular focus on innovative oncology therapies. The position offers an opportunity to combine scientific expertise with clinical project management in a dynamic biotechnology environment.

• Support the planning, coordination, and execution of clinical trials in collaboration with a senior team member in accordance with ICH-GCP and applicable regulations.
• Contribute to the preparation and scientific review of key clinical trial documentation.
• Coordinate and support clinical trial start-up activities, including site activation.
• Conduct scientific literature reviews, analyze clinical and preclinical data, and support the preparation of scientific reports and presentations.

• Advanced university degree (PhD) in Life Sciences, Pharmaceutical Sciences or a related scientific discipline.
• Strong scientific and analytical skills, with the ability to critically evaluate scientific literature and interpret experimental and clinical data.
• Demonstrated interest in oncology, drug development, and translational and clinical research.
• Excellent organizational, communication, and scientific writing skills. Proactive, detail-oriented, and capable of working in multidisciplinary teams.
• Excellent command of English, both written and spoken.
• Previous exposure to clinical research, biotechnology, or pharmaceutical development is advantageous but not mandatory.

An opportunity to contribute to the development of innovative cancer therapies while gaining hands-on experience across scientific, clinical, and strategic aspects of drug development.